- Home
- DSGX vs MEDP Comparison
DSGX vs MEDP Comparison
Compare DSGX & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSGX
- MEDP
- Stock Information
- Founded
- DSGX 1981
- MEDP 1992
- Country
- DSGX Canada
- MEDP United States
- Employees
- DSGX N/A
- MEDP N/A
- Industry
- DSGX Computer Software: Prepackaged Software
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- Sector
- DSGX Technology
- MEDP Health Care
- Exchange
- DSGX Nasdaq
- MEDP Nasdaq
- Market Cap
- DSGX 8.8B
- MEDP 8.5B
- IPO Year
- DSGX 1999
- MEDP 2016
- Fundamental
- Price
- DSGX $100.83
- MEDP $323.29
- Analyst Decision
- DSGX Buy
- MEDP Hold
- Analyst Count
- DSGX 7
- MEDP 11
- Target Price
- DSGX $125.14
- MEDP $338.90
- AVG Volume (30 Days)
- DSGX 490.9K
- MEDP 414.8K
- Earning Date
- DSGX 06-04-2025
- MEDP 07-21-2025
- Dividend Yield
- DSGX N/A
- MEDP N/A
- EPS Growth
- DSGX 17.84
- MEDP 33.36
- EPS
- DSGX 1.65
- MEDP 13.09
- Revenue
- DSGX $668,391,000.00
- MEDP $2,156,580,000.00
- Revenue This Year
- DSGX $11.87
- MEDP $5.64
- Revenue Next Year
- DSGX $13.36
- MEDP $3.32
- P/E Ratio
- DSGX $61.81
- MEDP $24.51
- Revenue Growth
- DSGX 13.74
- MEDP 9.87
- 52 Week Low
- DSGX $90.61
- MEDP $250.05
- 52 Week High
- DSGX $124.31
- MEDP $459.77
- Technical
- Relative Strength Index (RSI)
- DSGX 42.97
- MEDP 62.89
- Support Level
- DSGX $100.00
- MEDP $305.69
- Resistance Level
- DSGX $103.76
- MEDP $326.75
- Average True Range (ATR)
- DSGX 2.23
- MEDP 8.17
- MACD
- DSGX 0.32
- MEDP 1.88
- Stochastic Oscillator
- DSGX 49.72
- MEDP 89.41
About DSGX Descartes Systems Group Inc. (The)
Descartes Systems Group provides a software solution that allows users in the shipping industry to communicate with one another. Its core product is the Global Logistics Network, which is best understood as transaction-driven. Descartes charges clients to send/receive messages, data, and documents on the GLN. Customers typically contract for a monthly minimum over a multiyear period. The GLN platform allows Descartes to upsell additional software modules as well, typically provided via a software-as-a-service model.
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the US, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.